Form 4 for IONS IONIS PHARMACEUTICALS INC
Accepted 2025-11-20 00:00:00 ET · period of report 2025-11-18 · accession 0000874015-25-000282 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-11-20 | 2025-11-18 | IONS | WENDER JOSEPH H | Dir | M - OptEx | $24.42 | +16.0K | 16.0K | New | +$390.7K |
| D | 2025-11-20 | 2025-11-18 | IONS | WENDER JOSEPH H | Dir | M - OptEx | $0.00 | -16.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-18 | M | A | 16,000 | $24.42 | 16,000 | D | — | — | (F1) Acquired as a result of exercising a stock option that was scheduled to expire on 6/30/2026. |
| 2 | Derivative | Non-Qualified Stock Option (right to buy) | 2025-11-18 | M | D | 16,000 | $0.00 | 0 | D | $24.42 · 2017-07-01 to 2026-06-30 | 16,000 Common Stock |